drugset / Trial / NCT00742573

Incorporating Patient Treatment Choice to Improve Treatment Retention in Depressed Hispanics

NCT00742573

RandomizedParallel-groupSingle-blindTreatment

Summary

This study will determine whether combination treatment driven by patient choice is better than standardized medication treatment at retaining and improving Hispanic patients with major depressive disorder.

Timeline

Start
2008-08
Primary completion
2014-01-10
Completion
2014-01-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule
Subject Citalopram Small molecule
Subject Duloxetine Small molecule
Subject Escitalopram Small molecule
Subject Mirtazapine Other / unclassified
Subject Nortriptyline Small molecule
Subject Paroxetine Small molecule
Subject Sertraline Small molecule
Subject Venlafaxine Small molecule